Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07686913 · ClinicalTrials.gov registry record · NA
Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions
A NA study, sponsored by Riverside University Health System Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 610
- Enrollment target
NCT07686913 is a NA study that is actively recruiting participants, run by Riverside University Health System Medical Center. The registered enrollment target is 610 participants.
The verdict
NCT07686913, a NA study, is actively recruiting participants, sponsored by Riverside University Health System Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 610 participants
- Enrollment target
Study Summary
This study is evaluating whether Steri-Strips® provide additional benefits when used after cesarean section (C-section) surgery. Steri-Strips are adhesive strips that are commonly placed over a surgical incision to provide support while the wound heals. At our hospital, Steri-Strips are routinely used after C-sections in addition to standard wound closure techniques, although they are not considered part of the standard recommended closure method. Researchers want to determine whether adding Steri-Strips actually reduces wound complications such as infection, fluid collection under the skin, or reopening of the incision. Previous studies have shown mixed results, with some suggesting little difference in wound healing outcomes while others reported differences in scar appearance. Steri-Strips may also increase costs, add time to the surgery, and occasionally cause skin irritation or allergic reactions. Participants in this study will be randomly assigned to one of two groups. One group will receive standard cesarean wound closure with Steri-Strips, while the other group will receive standard wound closure without Steri-Strips. Researchers will compare wound healing, complications, patient outcomes, and costs between the two groups. The goal of this study is to determine whether Steri-Strips improve recovery after cesarean delivery and whether their routine use is beneficial and cost-effective. The findings may help guide future recommendations for cesarean wound care and improve outcomes for patients undergoing C-section delivery.
Interventions
- DEVICE Steri-Strip™ Skin Closures
- PROCEDURE Standard Cesarean Wound Closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07686913
The ClinicalTrials.gov registry entry for NCT07686913 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Riverside University Health System Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Steri-Strip™ Skin Closures is the first listed.
NCT07686913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07686913 about?
NCT07686913 is a clinical study titled "Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions". This study is evaluating whether Steri-Strips® provide additional benefits when used after cesarean section (C-section) surgery. Steri-Strips are adhesive strips that are commonly placed over a surgical incision to provide support while the wound heals. At our hospital, Steri-Strips are routinely us...
What is the current status of trial NCT07686913?
This trial is currently recruiting. It is a NA study. The enrollment target is 610 participants. The study started on 2026-06. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07686913?
The interventions under investigation include: Steri-Strip™ Skin Closures (DEVICE), Standard Cesarean Wound Closure (PROCEDURE).
Who is sponsoring clinical trial NCT07686913?
This trial is sponsored by Riverside University Health System Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.